ReviewNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives.

Vikram Bhise et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.